{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:49:56Z","timestamp":1762444196613},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.humpath.2010.04.001","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T08:47:18Z","timestamp":1280998038000},"page":"1448-1455","source":"Crossref","is-referenced-by-count":11,"title":["Differential expression of CKS-1B in typical and blastoid variants of mantle cell lymphoma"],"prefix":"10.1016","volume":"41","author":[{"given":"Nalan","family":"Akyurek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Giaslakiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Knoblock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne V.","family":"Abruzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios Z.","family":"Rassidakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2010.04.001_bib1","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","first-page":"229","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.humpath.2010.04.001_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2010.04.001_bib3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.humpath.2010.04.001_bib4","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.humpath.2010.04.001_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90572-X","article-title":"Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals","volume":"78","author":"Polyak","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2010.04.001_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2010.04.001_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","article-title":"Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor","volume":"153","author":"Quintanilla-Martinez","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2010.04.001_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.leu.2403337","article-title":"Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders","volume":"18","author":"Letestu","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2010.04.001_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.04.001_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7624798","article-title":"Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27","volume":"269","author":"Pagano","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.humpath.2010.04.001_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/12013","article-title":"SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27","volume":"1","author":"Carrano","year":"1999","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.humpath.2010.04.001_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1097-2765(01)00210-6","article-title":"A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1","volume":"7","author":"Spruck","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2010.04.001_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35060126","article-title":"The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)- mediated ubiquitinylation of p27","volume":"3","author":"Ganoth","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2010.04.001_bib14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0006-291X(03)00469-8","article-title":"High expression of Cks1 in human non-small cell lung carcinomas","volume":"303","author":"Inui","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humpath.2010.04.001_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ijc.21902","article-title":"Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer","volume":"119","author":"Ouellet","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2010.04.001_bib16","first-page":"5693","article-title":"Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma","volume":"9","author":"Masuda","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2010.04.001_bib17","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1038\/sj.onc.1208214","article-title":"Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling","volume":"24","author":"Ouellet","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2010.04.001_bib18","doi-asserted-by":"crossref","first-page":"R737","DOI":"10.1186\/bcr1278","article-title":"The expression of the ubiquitin ligase subunit Cks1 in human breast cancer","volume":"7","author":"Slotky","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2010.04.001_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/07357900802239116","article-title":"The expression and prognostic significance of Cks1 in salivary cancer","volume":"27","author":"Nagler","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1016\/j.humpath.2010.04.001_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20172","article-title":"Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma","volume":"100","author":"Shapira","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2010.04.001_bib21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/cncr.20917","article-title":"The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma","volume":"103","author":"Shapira","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2010.04.001_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/modpathol.3800762","article-title":"Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray","volume":"20","author":"Li","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2010.04.001_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.juro.2007.03.002","article-title":"Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma","volume":"178","author":"Kawakami","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2010.04.001_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.23548","article-title":"Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death","volume":"123","author":"Lan","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2010.04.001_bib25","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","article-title":"Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma","volume":"169","author":"Peponi","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2010.04.001_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.pai.0000143786.62974.66","article-title":"Differential expression of WT1 gene product in non-Hodgkin lymphomas","volume":"13","author":"Drakos","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2010.04.001_bib27","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.5858\/2000-124-1457-MIAOTC","article-title":"Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma","volume":"124","author":"Izban","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2010.04.001_bib28","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/modpathol.3800668","article-title":"MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast","volume":"19","author":"Talwalkar","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2010.04.001_bib29","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/cncr.24506","article-title":"Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine","volume":"115","author":"Inamdar","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2010.04.001_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2010.04.001_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00019606-200303000-00005","article-title":"Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV","volume":"12","author":"de Vos","year":"2003","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.humpath.2010.04.001_bib32","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2002-01-0263","article-title":"Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis","volume":"101","author":"Quintanilla-Martinez","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.04.001_bib33","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0002-9440(10)62571-0","article-title":"S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase","volume":"160","author":"Chiarle","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2010.04.001_bib34","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1182\/blood.V100.8.2950","article-title":"Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index","volume":"100","author":"Lim","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.04.001_bib35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2009.01.028","article-title":"Role of Cks1 amplification and overexpression in breast cancer","volume":"379","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humpath.2010.04.001_bib36","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","article-title":"Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma","volume":"111","author":"Dal Col","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.04.001_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1756-9966-27-51","article-title":"Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study","volume":"27","author":"Liu","year":"2008","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T15:43:57Z","timestamp":1635954237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817710001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0046817710001164"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2010.04.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}